DRIO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DRIO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
DarioHealth's operating cash flow per share for the three months ended in Dec. 2023 was $-0.25. DarioHealth's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.07.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 28.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 34.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 46.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for DarioHealth's Operating Cash Flow per Share or its related term are showing as below:
During the past 12 years, DarioHealth's highest 3-Year average Operating Cash Flow per Share Growth Rate was 65.10% per year. The lowest was 28.90% per year. And the median was 40.10% per year.
The historical data trend for DarioHealth's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DarioHealth Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Operating Cash Flow per Share | Get a 7-Day Free Trial | -6.94 | -2.97 | -3.04 | -2.02 | -1.07 |
DarioHealth Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Operating Cash Flow per Share | Get a 7-Day Free Trial | -0.31 | -0.17 | -0.34 | -0.30 | -0.25 |
For the Health Information Services subindustry, DarioHealth's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where DarioHealth's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
DarioHealth's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share (A: Dec. 2023 ) | = | Cash Flow from Operations (A: Dec. 2023 ) | / | Shares Outstanding (Diluted Average) (A: Dec. 2023 ) |
= | -30.379 | / | 28.372 | |
= | -1.07 |
DarioHealth's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share (Q: Dec. 2023 ) | = | Cash Flow from Operations (Q: Dec. 2023 ) | / | Shares Outstanding (Diluted Average) (Q: Dec. 2023 ) |
= | -7.341 | / | 28.902 | |
= | -0.25 |
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of DarioHealth's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Jon H. Kaplan | director | 1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027 |
Erez Raphael | director, officer: Chief Executive Officer | 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900 |
Dennis M Mcgrath | director | C/O PAVMED INC., ONE GRAND CENTRAL PLACE, STE. 4600, NEW YORK NY 10165 |
Dror Bacher | officer: Chief Operating Officer | 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK L3 3088900 |
Oded Cohen | officer: GM MSK | 8 HATOKHEN ST., CAESAREA INDUSTRIAL PARK L3 3088900 |
Adam K Stern | director | STERN AEGIS VENTURES, 810 7TH AVENUE 22ND FLOOR, NEW YORK NY 10019 |
Dennis Matheis | director | 8 HATOKHEN ST., CAESAREA L3 38900 |
Yoav Shaked | director | 8 HATOKHEN ST., CAESAREA L3 3088900 |
Yadin Shemmer | director | 8 HATOKHEN ST., CAESAREA L3 3088900 |
Richard Allan Anderson | officer: President, GM of North America | C/O DARIOHEALTH CORP., 18 W. 18TH ST, 5TH FLOOR, NEW YORK NY 10011 |
Yalon Farhi | director | C/O LABSTYLE INNOVATIONS CORP., 9 HALAMISH ST., CAESAREA INDUSTRIAL PARK, CAESAREA L3 3088900 |
Hila Karah | director | 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900 |
Zvi Ben-david | officer: Chief Financial Officer | 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900 |
Glen Moller | director | 8 HATOKHEN ST., CAESAREA L3 3088900 |
Olivier Roger Jarry | officer: See Remarks | 15 ROCKRIDGE RD, LARCHMONT NY 10538-3918 |
From GuruFocus
By PRNewswire • 08-02-2023
By PRNewswire PRNewswire • 06-01-2023
By PRNewswire • 10-30-2023
By PRNewswire PRNewswire • 05-04-2023
By PRNewswire • 01-11-2024
By PRNewswire • 11-21-2023
By PRNewswire • 08-15-2023
By PRNewswire • 07-24-2023
By PRNewswire • 07-06-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.